Phase 2 Readout
KYTX: Phase 2 Readout: kyv-101
June 30, 2026 · kyv-101. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2026
- Company
- Kyverna Therapeutics, Inc. (KYTX)
- Drug
- kyv-101
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: kyv-101
- Drug
- kyv-101
- Indication
- stiff person syndrome